Skip to main content

Seaport Therapeutics, Inc.

SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002042347

In the last 90 days, Seaport Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q3 2026, worth $766.9M in total; no superinvestor holds it.

Holders of 5% or more of SPTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Seaport Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SPTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
PureTech LYT, Inc.13G31.20%16.7M sharesNewAug 14, 20261 filingAug 14, 2026SEC
ARCH Venture Fund XII, L.P.13D11.90%6.29M sharesNewMay 6, 20261 filingMay 6, 2026SEC
General Atlantic LLC13D11.50%6.10M sharesNewMay 11, 20261 filingMay 11, 2026SEC
Zohar Daphne13G9.10%5.23M sharesNewAug 5, 20261 filingAug 5, 2026SEC
Paul Steven M13G6.30%3.52M sharesNewAug 5, 20261 filingAug 5, 2026SEC
Goldman Sachs Group Inc13G5.50%2.79M sharesNewMay 11, 20261 filingMay 11, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Seaport Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SPTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20264:30 PM ETPureTech LYT, Inc.and 2 others13G31.20%16.7M sharesNewJun 30, 2026SEC
Aug 5, 20268:06 AM ETZohar Daphne13G9.10%5.23M sharesNewJun 30, 2026SEC
Aug 5, 20266:01 AM ETPaul Steven M13G6.30%3.52M sharesNewJun 30, 2026SEC
May 11, 20267:54 PM ETGeneral Atlantic LLCand 13 others13D11.50%6.10M sharesNewMay 4, 2026SEC
May 11, 20263:19 PM ETGoldman Sachs Group Incand 1 other13G5.50%2.79M sharesNewMay 6, 2026SEC
May 6, 20264:26 PM ETARCH Venture Fund XII, L.P.and 6 others13D11.90%6.29M sharesNewMay 4, 2026SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Seaport Therapeutics, Inc. shares.

No Form 144 notices for Seaport Therapeutics, Inc. are on file.